Kawasaki disease: pathophysiology and insights from mouse models | Nature Reviews Rheumatology
Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms | Circulation
Mortality among Children with Kawasaki Disease in Japan | NEJM
Kawasaki disease and coronary involvement – All About Cardiovascular System and Disorders
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Kawasaki disease: AHA statement and recommendations
Kawasaki Disease: Signs, Symptoms and Diagnosis | American Heart Association
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey | Pediatric Rheumatology | Full Text
Frontiers | Antibodies and Immunity During Kawasaki Disease
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Kawasaki Disease: Complications and Treatment | American Heart Association
Kawasaki disease - MEDizzy
Kawasaki disease and coronary involvement – All About Cardiovascular System and Disorders
Homeopathy treatment for Kawasaki disease - Sofea Homeopathy Center
Kawasaki Disease: Causes, Symptoms & Diagnosis
Diagnosis and Management of Kawasaki Disease | AAFP
RACGP - Kawasaki disease – the importance of prompt recognition and early referral
A) Worldwide incidence of Kawasaki disease per 100,000 children... | Download Scientific Diagram
![PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d8f3d0e9bcb78fb7089e50d6f77d0efc0737cd69/5-Figure1-1.png "PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar")
PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar
Diagnosis and Management of Kawasaki Disease | AAFP
Kawasaki disease: AHA statement and recommendations
Understanding Kawasaki Disease
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Kawasaki disease: AHA statement and recommendations
Kawasaki disease - Wikipedia
